Like most people these days, I have been experimenting with various artificial intelligence (AI) tools this past year. It’s ...

Bristol Myers Squibb (BMS) has announced positive results from a phase 3b/4 study of its oral TYK2 inhibitor Sotyktu ...

Medscape wants to take the opportunity to look back and recap what was accomplished at ESC 2024. At this year’s event, ...

Eli Lilly has announced that it is investing $4.5bn into a new US facility for advanced manufacturing and drug development. The Lilly Medicine Foundry will give the company the ability to research new ...

Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and adaptability critical for success. Our worldwide team of 190,000 ...

Research on the state of the customer experience (CX) that the global pharmaceutical industry provides to healthcare professionals (HCPs) has been released by DT Consulting, an Indegene company. For ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) as an add-on maintenance treatment for chronic obstructive pulmonary disease (COPD). The ...

NHS England has announced that hundreds of babies have begun to be tested for over 200 genetic conditions as part of a study led by Genomics England. The Generation Study is evaluating the potential ...

During a recent media audit on sickle cell disease, an intriguing pattern emerged that the name ‘Christopher’ was the third most mentioned term. This unexpected finding resonated with me, as I share ...

We recently had the privilege of attending the European Society for Medical Oncology (ESMO). With over 40,000 oncology professionals from 177 countries, ESMO stands as a global leader in oncology ...

Weinberg Group The Weinberg Group is the global leader in regulatory and compliance services. We have provided biotech, medical device and pharmaceutical consulting services for over 30 years. This is ...